Elanco's Groundbreaking Approval for Credelio Quattro™
Elanco Animal Health Incorporated (NYSE: ELAN) has recently achieved a significant milestone in animal health with the approval of Credelio Quattro™. This innovative chewable tablet stands out as the first and only canine oral parasiticide that offers protection against an impressive six parasites. These include common threats such as fleas and ticks, as well as dangerous heartworms, roundworms, hookworms, and three kinds of tapeworms, effectively filling the gaps many traditional products leave behind.
Addressing Growing Parasite Risks
With warming climates and changing social habits, pet owners face increased exposure to parasites. This challenge is compounded by the rising awareness of public health risks associated with these parasites, some of which can be zoonotic, meaning they can be transmitted from pets to humans. Veterinarians universally recommend voracious protection against these parasites—a responsibility that falls on pet owners' shoulders.
The Credelio Quattro™ Advantage
What sets Credelio Quattro apart is its ease of use—just one chewable tablet per month. This formulation not only simplifies pet care routines but also ensures comprehensive protection from multiple parasites. Designed for dogs eight weeks and older, Credelio Quattro is expected to launch in early 2025, offering timely and effective solutions for pet owners.
Expert Endorsements on Zoonotic Risks
Elanco's commitment to animal and human health is echoed by its team of veterinarians. Dr. David Gosche, the U.S. Pet Health Medical Director, emphasizes the significant threat of zoonotic diseases, highlighting the case of a tapeworm discovered in an everyday backyard setting. "Zoonotic disease impacts millions each year, and by providing the right medications, we can protect both our pets and ourselves."
The Importance of Year-Round Treatment
In the modern landscape of pet care, Dr. Gosche advocates for consistent prevention strategies against zoonotic parasites, recommending Credelio Quattro as a reliable solution for pet owners. By administering this monthly treatment, both pets and their families can enjoy peace of mind against potentially harmful infections.
Unveiling Effective Features of Credelio Quattro™
Credelio Quattro not only helps protect against external parasites but also combats internal threats effectively. It begins killing ticks and fleas within four hours and achieves over 99% flea extermination within a day. Laboratory studies indicate full protection from heartworm disease after just one dose. Comparisons have shown that the ingredient lotilaner acts twice as quickly against ticks compared to its competitors, providing pet owners with faster response times.
Taste and Safety Matter
Designed with care, Credelio Quattro is gentle enough for puppies as light as 3.3 pounds and comes in a delectable beef flavor that simplifies administration. It functions both as a controller and treatment for various intestinal parasites, offering the broadest protection in a single dose.
Elanco's Ongoing Commitment to Pet Care
Credelio Quattro marks a significant addition to Elanco's extensive portfolio, complementing existing products like Seresto® and the Advantage® range. This new chewable not only enhances the quality of life for pets but also strengthens Elanco’s position as a leader in innovative animal health solutions. With nearly 70 years of expertise, Elanco is devoted to enriching lives through its dedicated work in animal welfare, sustainability, and community impact.
Frequently Asked Questions
What is Credelio Quattro™?
Credelio Quattro™ is an FDA-approved chewable tablet designed to protect dogs against six types of parasites in a single monthly dose.
How does Credelio Quattro™ work?
This formulation includes multiple active ingredients that work together to kill fleas, ticks, heartworms, and other intestinal parasites effectively and swiftly.
When will Credelio Quattro™ be available?
The expected launch for Credelio Quattro™ is in the first quarter of 2025.
Is it safe for all dogs?
Credelio Quattro™ is safe for dogs eight weeks old and older, weighing at least 3.3 pounds.
What makes Credelio Quattro™ unique?
It is the first oral parasiticide to combine four active ingredients for broad-spectrum protection, addressing both external and internal parasites effectively.
